相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Designing chimeric antigen receptors to effectively and safely target tumors
Michael C. Jensen et al.
CURRENT OPINION IN IMMUNOLOGY (2015)
Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer
Christina Twyman-Saint Victor et al.
NATURE (2015)
Effector T Cells Boost Regulatory T Cell Expansion by IL-2, TNF, OX40, and Plasmacytoid Dendritic Cells Depending on the Immune Context
Audrey Baeyens et al.
JOURNAL OF IMMUNOLOGY (2015)
The Nonsignaling Extracellular Spacer Domain of Chimeric Antigen Receptors Is Decisive for In Vivo Antitumor Activity
Michael Hudecek et al.
CANCER IMMUNOLOGY RESEARCH (2015)
Elevation of MMP-9 and IDO induced by pancreatic cancer cells mediates natural killer cell dysfunction
Yun-Peng Peng et al.
BMC CANCER (2014)
A Validated miRNA Profile Predicts Response to Therapy in Esophageal Adenocarcinoma
Heath D. Skinner et al.
CANCER (2014)
The role of indoleamine 2,3-dioxygenase (IDO) in immune tolerance: Focus on macrophage polarization of THP-1 cells
Xian-Feng Wang et al.
CELLULAR IMMUNOLOGY (2014)
Long-lasting Disease Stabilization in the Absence of Toxicity in Metastatic Lung Cancer Patients Vaccinated with an Epitope Derived from Indoleamine 2,3 Dioxygenase
Trine Zeeberg Iversen et al.
CLINICAL CANCER RESEARCH (2014)
OX40 and IL-7 play synergistic roles in the homeostatic proliferation of effector memory CD4+ T cells
Satoshi Yamaki et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2014)
Enhanced suppressor function of TIM-3+FoxP3+ regulatory T cells
Anne-Sophie Gautron et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2014)
Human OX40 Tunes the Function of Regulatory T Cells in Tumor and Nontumor Areas of Hepatitis C Virus-Infected Liver Tissue
Silvia Piconese et al.
HEPATOLOGY (2014)
OX40 engagement depletes intratumoral Tregs via activating FcγRs, leading to antitumor efficacy
Yannick Bulliard et al.
IMMUNOLOGY AND CELL BIOLOGY (2014)
Selective targeting of Toll-like receptors and OX40 inhibit regulatory T-cell function in follicular lymphoma
Kui Shin Voo et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Ideal Timing of Immunotherapy With Radiation in Murine Tumor Models
K. Young et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2014)
Lymphopenia Association With Gross Tumor Volume and Lung V5 and Its Effects on Non-Small Cell Lung Cancer Patient Outcomes
Chad Tang et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2014)
Irradiation and anti-PD-L1 treatment synergistically promote antitumor immunity in mice
Liufu Deng et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
IL-2: The First Effective Immunotherapy for Human Cancer
Steven A. Rosenberg
JOURNAL OF IMMUNOLOGY (2014)
Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial
Caroline Robert et al.
LANCET (2014)
MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer
Thomas Powles et al.
NATURE (2014)
Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients
Roy S. Herbst et al.
NATURE (2014)
Costimulation via the tumor-necrosis factor receptor superfamily couples TCR signal strength to the thymic differentiation of regulatory T cells
Shawn A. Mahmud et al.
NATURE IMMUNOLOGY (2014)
Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma
Alexandra Snyder et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Androgen receptor and microRNA-21 axis downregulates transforming growth factor beta receptor II (TGFBR2) expression in prostate cancer
S. Mishra et al.
ONCOGENE (2014)
Radiotherapy-Induced Anti-Tumor Immunity Contributes to the Therapeutic Efficacy of Irradiation and Can Be Augmented by CTLA-4 Blockade in a Mouse Model
Yuya Yoshimoto et al.
PLOS ONE (2014)
Focal Radiation Therapy Combined with 4-1BB Activation and CTLA-4 Blockade Yields Long-Term Survival and a Protective Antigen-Specific Memory Response in a Murine Glioma Model
Zineb Belcaid et al.
PLOS ONE (2014)
Tim-3 Negatively Mediates Natural Killer Cell Function in LPS-Induced Endotoxic Shock
Hongyan Hou et al.
PLOS ONE (2014)
Treatment of 4T1 Metastatic Breast Cancer with Combined Hypofractionated Irradiation and Autologous T-Cell Infusion
Alexander Filatenkov et al.
RADIATION RESEARCH (2014)
Combined Targeting of Costimulatory (OX40) and Coinhibitory (CTLA-4) Pathways Elicits Potent Effector T Cells Capable of Driving Robust Antitumor Immunity
William L. Redmond et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Combining Radiation and Immunotherapy: A New Systemic Therapy for Solid Tumors?
Chad Tang et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Tim-3: An Emerging Target in the Cancer Immunotherapy Landscape
Ana C. Anderson
CANCER IMMUNOLOGY RESEARCH (2014)
Toll-like receptors and cancer, particularly oral squamous cell carcinoma
Alison Mary Rich et al.
FRONTIERS IN IMMUNOLOGY (2014)
NK cells and T cells cooperate during the clinical course of colorectal cancer
Giuseppe Sconocchia et al.
ONCOIMMUNOLOGY (2014)
The indoleamine 2,3-dioxygenase pathway controls complement-dependent enhancement of chemo-radiation therapy against murine glioblastoma
Minghui Li et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2014)
Ipilimumab alone or in combination with radiotherapy in metastatic castration-resistant prostate cancer: results from an open-label, multicenter phase I/II study
S. F. Slovin et al.
ANNALS OF ONCOLOGY (2013)
OX40 Is a Potent Immune-Stimulating Target in Late-Stage Cancer Patients
Brendan D. Curti et al.
CANCER RESEARCH (2013)
NK cell-based immunotherapy for malignant diseases
Min Cheng et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2013)
Receptor Affinity and Extracellular Domain Modifications Affect Tumor Recognition by ROR1-Specific Chimeric Antigen Receptor T Cells
Michael Hudecek et al.
CLINICAL CANCER RESEARCH (2013)
The TNFRs OX40, 4-1BB, and CD40 as targets for cancer immunotherapy
Amy E. Moran et al.
CURRENT OPINION IN IMMUNOLOGY (2013)
Treatment of patients with advanced cancer with the natural killer cell line NK-92
Torsten Tonn et al.
CYTOTHERAPY (2013)
Suppression of natural killer-cell and dendritic-cell apoptotic tumoricidal activity in patients with head and neck cancer
Dejan Baskic et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2013)
Transforming Growth Factor β-1 (TGF-β1) Is a Serum Biomarker of Radiation Induced Fibrosis in Patients Treated With Intracavitary Accelerated Partial Breast Irradiation: Preliminary Results of a Prospective Study
Dustin L. Boothe et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2013)
Anti-PD-1 Blockade and Stereotactic Radiation Produce Long-Term Survival in Mice With Intracranial Gliomas
Jing Zeng et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2013)
The Abscopal Effect Associated With a Systemic Anti-melanoma Immune Response
Emily F. Stamell et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2013)
Inherited human OX40 deficiency underlying classic Kaposi sarcoma of childhood
Minji Byun et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
Antibodies Targeting Human OX40 Expand Effector T Cells and Block Inducible and Natural Regulatory T Cell Function
Kui S. Voo et al.
JOURNAL OF IMMUNOLOGY (2013)
Myeloid-Derived Suppressor Cells Suppress Antitumor Immune Responses through IDO Expression and Correlate with Lymph Node Metastasis in Patients with Breast Cancer
Jinpu Yu et al.
JOURNAL OF IMMUNOLOGY (2013)
Combining Radiotherapy and Cancer Immunotherapy: A Paradigm Shift
Silvia C. Formenti et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
Mutational heterogeneity in cancer and the search for new cancer-associated genes
Michael S. Lawrence et al.
NATURE (2013)
Circulating microRNA-21 as noninvasive predictive biomarker for response in cancer immunotherapy
Zhiyu Wang et al.
MEDICAL HYPOTHESES (2013)
Nivolumab plus Ipilimumab in Advanced Melanoma
Jedd D. Wolchok et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
The role of IL-6 in the radiation response of prostate cancer
Chun-Te Wu et al.
RADIATION ONCOLOGY (2013)
An Abscopal Response to Radiation and Ipilimumab in a Patient with Metastatic Non-Small Cell Lung Cancer
Encouse B. Golden et al.
CANCER IMMUNOLOGY RESEARCH (2013)
Phase I/II clinical trial of anti-OX40, radiation and cyclophosphamide in patients with prostate cancer: immunological analysis
Magdalena Kovacsovics-Bankowski et al.
Journal for ImmunoTherapy of Cancer (2013)
Tumor-targeted T cells modified to secrete IL-12 eradicate systemic tumors without need for prior conditioning
Hollie J. Pegram et al.
BLOOD (2012)
A phase 1 trial of the anti-inhibitory KIR mAb IPH2101 for AML in complete remission
Norbert Vey et al.
BLOOD (2012)
A phase 1 trial of the anti-KIR antibody IPH2101 in patients with relapsed/refractory multiple myeloma
Don M. Benson et al.
BLOOD (2012)
The Therapeutic Potential of MicroRNAs in Cancer
Stine B. Thorsen et al.
CANCER JOURNAL (2012)
Adoptive T-Cell Therapy Using Autologous Tumor-Infiltrating Lymphocytes for Metastatic Melanoma Current Status and Future Outlook
Richard Wu et al.
CANCER JOURNAL (2012)
Synergy of Topical Toll-like Receptor 7 Agonist with Radiation and Low-Dose Cyclophosphamide in a Mouse Model of Cutaneous Breast Cancer
M. Zahidunnabi Dewan et al.
CLINICAL CANCER RESEARCH (2012)
Induction of tumoricidal function in CD4+ T cells is associated with concomitant memory and terminally differentiated phenotype
Daniel Hirschhorn-Cymerman et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
C-Met Inhibitor MK-8003 Radiosensitizes c-Met-Expressing Non-Small-Cell Lung Cancer Cells With Radiation-Induced c-Met-Expression
Vikas Bhardwaj et al.
JOURNAL OF THORACIC ONCOLOGY (2012)
Immunotherapy of Cancer with 4-1BB
Dass S. Vinay et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Immunologic Correlates of the Abscopal Effect in a Patient with Melanoma
Michael A. Postow et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Safety, Activity, and Immune Correlates of Anti-PD-1 Antibody in Cancer
Suzanne L. Topalian et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
A Systemic Complete Response of Metastatic Melanoma to Local Radiation and Immunotherapy
Susan M. Hiniker et al.
TRANSLATIONAL ONCOLOGY (2012)
Targeting natural killer cells and natural killer T cells in cancer
Eric Vivier et al.
NATURE REVIEWS IMMUNOLOGY (2012)
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
NATURE REVIEWS CANCER (2012)
Coexpression of Tim-3 and PD-1 identifies a CD8+ T-cell exhaustion phenotype in mice with disseminated acute myelogenous leukemia
Qing Zhou et al.
BLOOD (2011)
Tumour suppressor microRNA-584 directly targets oncogene Rock-1 and decreases invasion ability in human clear cell renal cell carcinoma
K. Ueno et al.
BRITISH JOURNAL OF CANCER (2011)
IL-12 Release by Engineered T Cells Expressing Chimeric Antigen Receptors Can Effectively Muster an Antigen-Independent Macrophage Response on Tumor Cells That Have Shut Down Tumor Antigen Expression
Markus Chmielewski et al.
CANCER RESEARCH (2011)
Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy
Steven A. Rosenberg et al.
CLINICAL CANCER RESEARCH (2011)
RADIATION ENHANCES REGULATORY T CELL REPRESENTATION
Evelyn L. Kachikwu et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)
OX40 Complexes with Phosphoinositide 3-Kinase and Protein Kinase B (PKB) To Augment TCR-Dependent PKB Signaling
Takanori So et al.
JOURNAL OF IMMUNOLOGY (2011)
T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia
Michael Kalos et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Redirecting T-cell specificity by introducing a tumor-specific chimeric antigen receptor
Bipulendu Jena et al.
BLOOD (2010)
Natural killer cells and cancer: Regulation by the killer cell Ig-like receptors (KIR)
Amanda K. Purdy et al.
CANCER BIOLOGY & THERAPY (2010)
A phase I trial of adoptive transfer of allogeneic natural killer cells in patients with advanced non-small cell lung cancer
Eleni G. Iliopoulou et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
Clinical Responses in a Phase II Study Using Adoptive Transfer of Short-term Cultured Tumor Infiltration Lymphocytes in Metastatic Melanoma Patients
Michal J. Besser et al.
CLINICAL CANCER RESEARCH (2010)
Adoptive immunotherapy with genetically engineered T cells: modification of the IgG1 Fc 'spacer' domain in the extracellular moiety of chimeric antigen receptors avoids 'off-target' activation and unintended initiation of an innate immune response
A. Hombach et al.
GENE THERAPY (2010)
Evaluation of natural killer cell activity in pre and post treated breast cancer patients
Ahmad Piroozmand et al.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2010)
Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity
Kaori Sakuishi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Adjuvant Therapy With Agonistic Antibodies to CD134 (OX40) Increases Local Control After Surgical or Radiation Therapy of Cancer in Mice
Michael J. Gough et al.
JOURNAL OF IMMUNOTHERAPY (2010)
Chimeric Antigen Receptors Combining 4-1BB and CD28 Signaling Domains Augment PI3kinase/AKT/Bcl-XL Activation and CD8+ T Cell-mediated Tumor Eradication
Xiao-Song Zhong et al.
MOLECULAR THERAPY (2010)
Targeting microRNAs in cancer: rationale, strategies and challenges
Ramiro Garzon et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Preclinical characterization of 1-7F9, a novel human anti-KIR receptor therapeutic antibody that augments natural killer-mediated killing of tumor cells
Francois Romagne et al.
BLOOD (2009)
Multi-Institutional Phase I/II Trial of Stereotactic Body Radiation Therapy for Lung Metastases
Kyle E. Rusthoven et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Multi-Institutional Phase I/II Trial of Stereotactic Body Radiation Therapy for Liver Metastases
Kyle E. Rusthoven et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
NF-κB-Mediated HER2 Overexpression in Radiation-Adaptive Resistance
Ning Cao et al.
RADIATION RESEARCH (2009)
Anti-OX40 monoclonal antibody therapy in combination with radiotherapy results in therapeutic antitumor immunity to murine lung cancer
Hiroshi Yokouchi et al.
CANCER SCIENCE (2008)
Infusion of the allogeneic cell line NK-92 in patients with advanced renal cell cancer or melanoma: a phase I trial
S. Arai et al.
CYTOTHERAPY (2008)
CD28 costimulation is essential for human T regulatory expansion and function
Tatiana N. Golovina et al.
JOURNAL OF IMMUNOLOGY (2008)
IL-12 is required for anti-OX40-mediated CD4 T cell survival
Carl E. Ruby et al.
JOURNAL OF IMMUNOLOGY (2008)
Tumor-directed radiation and the immunotoxin SS1P in the treatment of mesothelin-expressing tumor xenografts
Raffit Hassan et al.
CLINICAL CANCER RESEARCH (2006)
Flt3L therapy following localized tumor irradiation generates long-term protective immune response in metastatic lung cancer: Its implication in designing a vaccination strategy
Prabir K. Chakravarty et al.
ONCOLOGY (2006)
The role of extracellular spacer regions in the optimal design of chimeric immune receptors - Evaluation of four different scFvs and antigens
RD Guest et al.
JOURNAL OF IMMUNOTHERAPY (2005)
分享论文
